Home » Bertuch, Metelitsa elected to ASCI for outstanding scholarly achievements in biomedical research
Alison Bertuch, M.D., Ph.D. and Leonid Metelitsa, M.D., Ph.D. were elected to join the American Society for Clinical Investigation (ASCI) for their outstanding records of scholarly achievement in biomedical research.
The physician-scientists are faculty members at Texas Children’s Cancer and Hematology Centers and Associate Professors of Pediatrics – Hematology/Oncology for Baylor College of Medicine.
Bertuch is the Program Director of the Bone Marrow Failure Program and a member of the Cancer Genetics and Genomics Program. Her research is aimed at understanding the mechanisms of telomere structure and function.
Metelitsa is a member of the Center for Cell and Gene Therapy (CAGT) research laboratories. His research is focused on Va24-Ja18-invariant Natural Killer T (iNKT) cells.
Founded in 1908, the ASCI is an honor society of physician-scientists who translate findings in the laboratory to the advancement of clinical practice. The Society has over 3,000 members who are in the upper ranks of academic medicine and industry.
The ASCI is dedicated to the advancement of research that extends our understanding and improves the treatment of human diseases, and members are committed to mentoring future generations of physician-scientists.
The ASCI considers the nominations of several hundred physician-scientists from all practices of medicine each year. Less than 80 new members are elected to join the Society every year in recognition of the significant research accomplishments. Elected members must have demonstrated exceptional research accomplishments early in their career and must be 50 years of age or younger at the time of their election.
Bertuch and Metelitsa will be officially welcomed into the ASCI at the annual ASCI Dinner and New Member Induction Ceremony on April 25, 2014, as part of the 2014 ASCI/AAP Joint Meeting.
by Corbin Dodge
Texas Children’s Cancer and Hematology Centers
April 4, 2014